Maple
PrivateLast Round
Early Funding
Aug 22, 2023
Est. Valuation
$227.4M
Total Funding Raised
$75.86M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Maple operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was an Early Funding round in August 2023.
Maple is a telehealth company that provides a virtual care platform connecting patients with licensed doctors and nurse practitioners for 24/7 diagnoses and prescription services.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Mental Health, Patient Engagement
Business Model
B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Maple Comparables
Compare Maple with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gotodoctor.ca | 84% | |
| Sun Life Financial Inc | 80% | |
| WELL Health Technologies | 79% |
For institutional investors. Book with your work email.
Maple Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 22, 2023 | ||||
| Series B | Sep 15, 2020 | ||||
| Series A | Sep 18, 2019 | ||||
| Series A | Mar 9, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Maple Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Royal Bank Of Canada | Series A |
| MaRS Discovery District | Series A |
| Prelude | Early Funding |
| GSR Ventures | Early Funding |
| Acton Capital | Series A |
| Veris Ventures | Early Funding |
| Maven 11 Capital | Early Funding |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
Grew 15% QoQ, from 241 to 278 employees.
- Apr 1, 2026
Reached 7,000 businesses and government partners on its platform.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 11, 2026
Maple launches the “Health Yeah!” platform as an on-demand and proactive health resource for patients and providers, with a focus on ADHD expertise.
For institutional investors. Book with your work email.
Maple Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Maple's valuation, stock price, and market status.
Is Maple a public or private company?
Maple is a private company.
What is the current stock price of Maple?
Maple is a private company, so its shares have no public market price. Caplight tracks Maple's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Maple worth (valuation)?
Maple's valuation is estimated at $227.4M based on funding round data.
Can I buy Maple stock?
Maple shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Maple's last funding round?
Maple's most recent funding round was Early Funding on August 22, 2023.
Who are the main investors in Maple?
Key investors in Maple include Acton Capital, BlockTower Capital, Tioga Capital.
Will Maple IPO soon?
No public IPO plans have been announced for Maple.
How can I track Maple secondary market activity?
Caplight tracks bids, offers, and trades in Maple's shares on secondary markets.